Sentence examples for markers in response from inspiring English sources

In the present study, we have determined influence of wearing CG during post-exercise period on changes in exercise performance and exercise-induced muscle damage markers in response to two repeated bouts of training sessions separated with 4 h of rest period.

Despite the strong relationships between sAA, sCgA and exercise intensity [14], factors other than SNS activity, such as parasympathetic activity, reflex activity or, in the case of SCI, receptor hypersensitivity [26], may also contribute to the changes observed in these salivary markers in response to exercise.

We therefore studied the expression of ER-stress markers in response to palmitate with, or without TO1317.

This assay allows the study of the recruitment of axonal markers in response to contact with non-neuronal cells expressing a specific neuroligin isoform [13], [41].

The high percentage of BM-MSC colonies expressing tenocytic markers in response to BMP-12 induction (over 85% were positive for Scx and Tnmd) not only demonstrates its effectiveness as an inducer of tenocyte differentiation, but also indicates that the tenocyte pathway of differentiation is preferred under the conditions of this experiment.

In order to examine expression of Iba-1 (a microglial marker), GFAP (an astrocytic marker), ED2/CD163 (a perivascular cell marker) and CB1/CB2 receptor and CB1/CB2 receptor co-localization with other cell markers in response to paw incision, untreated animals received paw incision surgery and were perfused as described below on days 1, 3 and 9 after surgery (n = 4 each).

So why didn't the Obama administration lay down an even stronger marker in response to this breakout -- by threatening, say, to intercept ships at sea that it believed were carrying parts for the Iranian nuclear program?

Special consideration should be made for using PI uptake as a cell viability marker and phosphatidylserine externalization as an apoptosis marker in response to electric field stimulation.

Studies with bone forming agents such as parathyroid hormone and sclerostin monoclonal antibody have shown that osteocalcin is a less sensitive marker in response to treatments [ 10, 11].

In the present study,  99mTc labelled infliximab was used to study the expression of TNF α in sarcoid lesions and to evaluate its role as a predictive marker in response to therapy with Remicade.

Table 1 shows the co-distribution of an adverse event and a risk marker in response to standard treatment in two hypothetical populations of 1000 patients each and with similar relative risks and odds ratios, but with different sensitivities (18% vs. 89%, respectively) and precisions (9.1% vs. 3.7%) in toxicity prediction.